In our study, prostate biopsy was performed in all patients and we did not see any significant difference in PSA levels in patient groups with and without prostate cancer (26.86 ± 23.84%, 23.52% ± 21.78, respectively, p > 0.05). Here, KLK3 is linked to prostate cancer.